Envoy Group Corp

November 23, 2015 09:15 ET

Envoy Seeks Acquisitions

VALENCIA, CALIFORNIA--(Marketwired - Nov. 23, 2015) - Envoy Group Corp (OTC:ENVV) effective immediately Envoy Group Corp announces a restructuring of its business plan to reprioritize and become an acquirer within the consumer products market. Under the new plan new opportunities, products and companies will be brought into the Envoy Group umbrella for exciting strategic acquisitions and joint ventures.

To this end Envoy has recently entered into negotiations with two exciting premium brand retail product opportunities, Tryst Electronic Smoking Products and the other in the energy drink space, further details to follow.

Incorporating the highest quality, Tryst is already the market leader in Electronic Cigars with their Rubusto and Panatella E-Cigars. Tryst products are now carried by 17 major distributors.

Harp Sangha, Envoy's CEO comments, "The Envoy team have spent the last six months diligently reviewing and discussing many product opportunities. We are delighted to be advancing two major deals this month."

Envoy Group is planning a comprehensive, marketing and distribution campaign that will strategically and effectively align the products to consumer demand either on-line or on-shelf.

For further information please see our investor profile available on our website: www.envoygroupcorp.com.

Safe Harbor Statements

Certain information contained in this news release constitutes "forward-looking statements" as such term is used in applicable United States and Canadian laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "estimates", "intends" or "believes", or that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur", or "be achieved". Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these factors are beyond the Company's ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company's filings with the SEC. Such risks and other factors include, among others, the ability to locate and acquire suitable interests in alternative medicine manufacturing operations on terms acceptable to the Company, the availability of financing on acceptable terms, accidents, labor disputes, acts of God and other risks of the alternative medicine industry including, without limitation, delays in obtaining governmental approvals or permits, title disputes or claims limitations on insurance coverage. The Company believes that the expectations reflected in the forward-looking statements included in this news release are reasonable; however, no assurance can be given that these expectations will prove to be correct, and such forward-looking statements should not be unduly relied upon. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.

Contact Information